
TECVAYLI and DARZALEX FASPRO Show Strong Myeloma Response
Johnson & Johnson shared encouraging results from an investigational treatment that combines TECVAYLI with DARZALEX FASPRO in patients newly diagnosed with multiple myeloma who are
Johnson & Johnson shared encouraging results from an investigational treatment that combines TECVAYLI with DARZALEX FASPRO in patients newly diagnosed with multiple myeloma who are
Varian, part of Siemens Healthineers, has successfully completed enrollment and treatment for its FAST-02 clinical trial, which studied the use of Flash radiotherapy to treat
AngioDynamics, Inc. a MedTech company focused on restoring healthy blood flow, improving cancer care, and enhancing quality of life, has enrolled the first patient in
Expanded indication makes SIR-Spheres the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer Sirtex Medical, a
Data360, Inc. has expanded its Fingerprint solution to identify audience intent daily. Fingerprint is Data360’s proprietary technology that identifies intent, which is then mapped to
Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and its underlying causes. Eligible